|
Home | Medical-Newswire.Com:
|
 (Medical-NewsWire.com, August 25, 2016 ) Publisher's analysis covers 70 iron ore operations accounting for over 1,300Mt of iron ore production globally, the majority of which is export production.Download sample report at: http://www.reportsweb.com/inquiry&RW0001270848/sampleOverall 30 companies...
Source: EmailWire.com
 (Medical-NewsWire.com, August 25, 2016 ) Download sample report @ http://www.reportsweb.com/inquiry&RW00020496/sample Report Summary This report reviews the performance and asset allocations of HNWIs and ultra-HNWIs in Nigeria. It also includes an evaluation of the local wealth management market....
Source: EmailWire.com
 (Medical-NewsWire.com, August 25, 2016 ) Operator Strategies to Increase Smartphone Penetration in Africa' report provides an overview of smartphone market in Africa and analyzes the various strategies telcos can leverage to increase smartphone penetration levels. Report URL: http://www.reportsweb.com/operator-strategies-to-increase-smartphone-penetration-in-africaIt...
Source: EmailWire.com
 (Medical-NewsWire.com, August 25, 2016 ) This report studies Infant Incubator in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.To Get Sample...
Source: EmailWire.com
 (Medical-NewsWire.com, August 25, 2016 ) This report studies Implantable Cardiac Pacemaker in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.To...
Source: EmailWire.com
 (Medical-NewsWire.com, August 25, 2016 ) Simcere is China’s first and world’s second manufacturer of edaravone injection. Its new product “Bi Cun” is priced at 1/33 of the price of similar products in Japan. In 2007, “Bi Cun” spread over China with a market share of...
Source: EmailWire.com
 (Medical-NewsWire.com, August 25, 2016 ) Developed by GD Searle & Pfizer, celecoxib came into the market in 1999 under the trade name of Celebrex. Ever since its debut in the US in Feb. 1999, celecoxib has been widely used and set a record for the largest amount of prescriptions among all the new...
Source: EmailWire.com
 (Medical-NewsWire.com, August 25, 2016 ) There are about 90 million diabetes patients in today’s China and 95% of them suffer from type 2 diabetes mellitus. And the number of potential patients might reach up to 200 million. For patients with type 1 diabetes mellitus, insulin is the only drug...
Source: EmailWire.com
 (Medical-NewsWire.com, August 25, 2016 ) After entering China, atorvastatin develops fast with annual sales value rising from less than CNY 70 million in 2005 to CNY 1.374 billion in 2014 and CAGR reaching up to 41% during 2005-2014. Atorvastatin enjoys a vast demand in China. And such companies...
Source: EmailWire.com
 (Medical-NewsWire.com, August 25, 2016 ) After entering China, recombinant factor ? develops fast with annual sales value rising from less than CNY 6 million in 2009 to CNY 93.78 million in 2014 and CAGR reaching up to 76.8% during 2009-2014. Currently, recombinant factor ? in the Chinese market...
Source: EmailWire.com
 (Medical-NewsWire.com, August 25, 2016 ) Tacrolimus in the Chinese market mainly comes from the following companies: Fujisawa Pharmaceutical Co., Ltd (Ireland), Hisun, Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, Sichuan Med-Shine Pharmaceutical Co., Ltd and Astellas Pharma Manufacturing,Inc,...
Source: EmailWire.com
 (Medical-NewsWire.com, August 25, 2016 ) Capecitabine enjoys a vast demand in China. Currently, there are mainly five manufacturers of capecitabine in China: Shanghai Roche Pharmaceutical Co., Ltd, Qilu Pharmaceutical Co., Ltd, Jiangsu Hengrui Medicine Co., Ltd and Chia Tai Tianqing Pharmaceutical...
Source: EmailWire.com
 (Medical-NewsWire.com, August 25, 2016 ) Liraglutide, a derivative attained by attaching a fatty acid molecule to GLP-1 molecule, can reduce the HbA1c level and weight of type 2 diabetes mellitus (T2DM) patients and improve the function of beta cells. Since it stimulates insulin secretion and inhibits...
Source: EmailWire.com
 (Medical-NewsWire.com, August 25, 2016 ) According to CRI’s statistics, tegafur, gimeracil and oteracil develops fast after entering China with annual sales rising from less than CNY 20 million in 2009 to CNY 707 million in 2014 and CAGR reaching up to 110% during the period of 2009-2014, which...
Source: EmailWire.com
 (Medical-NewsWire.com, August 25, 2016 ) Ever since insulin determir came into being, it has brought hope to patients with diabetes and has played an important role in diabetes treatment. With the advances in diabetes studies, the appearance of insulin analogue again cast new light on diabetes treatment....
Source: EmailWire.com
|
|
|
|
